Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
25.41
+0.24 (0.95%)
May 6, 2026, 3:00 PM CST

SHA:603983 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3031,2502,0321,0771,073806.1
Short-Term Investments
-154.4244.08279.64333.41115.15
Trading Asset Securities
355.94388.66395.7767.98437.78738.09
Cash & Short-Term Investments
1,6591,7932,4722,1241,8441,659
Cash Growth
-20.41%-27.45%16.36%15.19%11.14%-33.37%
Accounts Receivable
31.538.446.4331.573.9362.85
Other Receivables
6.9622.1211.5714.647.437.42
Receivables
38.4560.525846.1481.3670.26
Inventory
224.62233.35219.66171.73151.7138.43
Prepaid Expenses
-9.1812.52--4.9
Other Current Assets
391.15139.34192.31187.75159.99102.88
Total Current Assets
2,3132,2362,9542,5302,2371,976
Property, Plant & Equipment
907.94931.771,082769.91520.59384.14
Long-Term Investments
240.68261.03217.8563.6173.8775.12
Other Intangible Assets
390.93394.15699.16719.58748.63764.56
Long-Term Deferred Tax Assets
109.11110.8391.8559.142.1621.67
Long-Term Deferred Charges
25.221.231.743.172.589.98
Other Long-Term Assets
702.99658.5615.76308.41469.07530.38
Total Assets
4,6904,6135,0634,4544,0943,762
Accounts Payable
293.37188.12253.14178.15152.94154.46
Accrued Expenses
21.47209.28167.8156.78156.8104.95
Short-Term Debt
467395790.1100.07100-
Current Portion of Long-Term Debt
0.84--148.12.1-
Current Portion of Leases
-0.832.364.058.654.79
Current Income Taxes Payable
49.0520.6932.6715.4527.9824.76
Current Unearned Revenue
180.93184.82195.12240.494.53144.57
Other Current Liabilities
164.56200.08155.34167.19125.47143.02
Total Current Liabilities
1,1771,1991,5971,010668.47576.55
Long-Term Debt
----148-
Long-Term Leases
1.781.981.53.2511.6814.68
Long-Term Unearned Revenue
4.174.245.396.165.569.51
Long-Term Deferred Tax Liabilities
14.5714.2512.2615.237.852.45
Other Long-Term Liabilities
--0.360.36--
Total Liabilities
1,1981,2191,6161,035841.56603.19
Common Stock
401401401401401.44401.82
Additional Paid-In Capital
765.28765.28761760.45774.49780.12
Retained Earnings
2,2682,1672,2202,1872,0281,930
Treasury Stock
-----14.47-26.66
Comprehensive Income & Other
-1.76-1.73-1.71-1.58-1.49-1.28
Total Common Equity
3,4323,3313,3803,3473,1883,084
Minority Interest
60.4263.0266.171.4264.5174.36
Shareholders' Equity
3,4933,3943,4473,4193,2533,158
Total Liabilities & Equity
4,6904,6135,0634,4544,0943,762
Total Debt
469.62397.81793.97255.48270.4419.47
Net Cash (Debt)
1,1901,3961,6781,8691,5741,640
Net Cash Growth
-24.38%-16.82%-10.22%18.75%-4.03%-31.21%
Net Cash Per Share
2.973.504.174.683.894.10
Filing Date Shares Outstanding
404.08401401401401.44401.82
Total Common Shares Outstanding
404.08401401401401.44401.82
Working Capital
1,1361,0371,3581,5201,5691,399
Book Value Per Share
8.498.318.438.357.947.68
Tangible Book Value
3,0412,9372,6812,6282,4392,320
Tangible Book Value Per Share
7.537.326.696.556.085.77
Buildings
-911.4507.12476.51274.43274.43
Machinery
-108.2693.0485.3973.5263.46
Construction In Progress
-22.89603.06309.48253.24118.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.